TY - JOUR
T1 - Evaluation of automatically quantified foveal avascular zone metrics for diagnosis of diabetic retinopathy using optical coherence tomography angiography
AU - Lu, Yansha
AU - Simonett, Joseph M.
AU - Wang, Jie
AU - Zhang, Miao
AU - Hwang, Thomas
AU - Hagag, Ahmed M.
AU - Huang, David
AU - Li, Dengwang
AU - Jia, Yali
N1 - Funding Information:
Supported by Grants National Institutes of Health R01EY027833, National Institutes of Health DP3 DK104397, National Institutes of Health R01 EY024544, National Institutes of Health P30 EY010572 from the National Institutes of Health (Bethesda, MD, USA), and by unrestricted departmental funding from Research to Prevent Blindness (New York, NY, USA). This work was partially funded by the National Natural Science Foundation of China (No. 61471226), Natural Science Foundation for Distinguished Young Scholars of Shandong Province (No. JQ201516), and the Taishan scholar project of Shandong Province (No. tsqn20161023). Oregon Health & Science University (OHSU), DH, and YJ have a significant financial interest in Optovue, Inc., a company that may have a commercial interest in the results of this research and technology. These potential conflicts of interest have been reviewed and managed by OHSU.
Funding Information:
Supported by Grants R01EY027833, DP3 DK104397, R01 EY024544, P30 EY010572 from the National Institutes of Health (Bethesda, MD, USA), and by unrestricted departmental funding from Research to Prevent Blindness (New York, NY, USA). This work was partially funded by the National Natural Science Foundation of China (No. 61471226), Natural Science Foundation for Distinguished Young Scholars of Shandong Province (No. JQ201516), and the Taishan scholar project of Shandong Province (No. tsqn20161023). Oregon Health & Science University (OHSU), DH, and YJ have a significant financial interest in Optovue, Inc., a company that may have a commercial interest in the results of this research and technology. These potential conflicts of interest have been reviewed and managed by OHSU.
Publisher Copyright:
© 2018 The Authors.
PY - 2018/5
Y1 - 2018/5
N2 - Purpose: To describe an automated algorithm to quantify the foveal avascular zone (FAZ), using optical coherence tomography angiography (OCTA), and to compare its performance for diagnosis of diabetic retinopathy (DR) and association with best-corrected visual acuity (BCVA) to that of extrafoveal avascular area (EAA). Methods: We obtained 3 × 3-mm macular OCTA scans in diabetic patients with various levels of DR and healthy controls. An algorithm based on a generalized gradient vector flow (GGVF) snake model detected the FAZ, and metrics assessing FAZ size and irregularity were calculated. We compared the automated FAZ segmentation to manual delineation and tested the within-visit repeatability of FAZ metrics. The correlations of two conventional FAZ metrics, two novel FAZ metrics, and EAA with DR severity and BCVA, as determined by Early Treatment Diabetic Retinopathy Study (ETDRS) charts, were assessed. Results: Sixty-six eyes from 66 diabetic patients and 19 control eyes from 19 healthy participants were included. The agreement between manual and automated FAZ delineation had a Jaccard index > 0.82, and the repeatability of automated FAZ detection was excellent in eyes at all levels of DR severity. FAZ metrics that incorporated both FAZ size and shape irregularity had the strongest correlation with clinical DR grade and BCVA. Of all the tested OCTA metrics, EAA had the greatest sensitivity in differentiating diabetic eyes without clinical evidence of retinopathy, mild to moderate nonproliferative DR (NPDR), and severe NPDR to proliferative DR from healthy controls. Conclusions: The GGVF snake algorithm tested in this study can accurately and reliably detect the FAZ, using OCTA data at all DR severity grades, and may be used to obtain clinically useful information from OCTA data regarding macular ischemia in patients with diabetes. While FAZ metrics can provide clinically useful information regarding macular ischemia, and possibly visual acuity potential, EAA measurements may be a better biomarker for DR.
AB - Purpose: To describe an automated algorithm to quantify the foveal avascular zone (FAZ), using optical coherence tomography angiography (OCTA), and to compare its performance for diagnosis of diabetic retinopathy (DR) and association with best-corrected visual acuity (BCVA) to that of extrafoveal avascular area (EAA). Methods: We obtained 3 × 3-mm macular OCTA scans in diabetic patients with various levels of DR and healthy controls. An algorithm based on a generalized gradient vector flow (GGVF) snake model detected the FAZ, and metrics assessing FAZ size and irregularity were calculated. We compared the automated FAZ segmentation to manual delineation and tested the within-visit repeatability of FAZ metrics. The correlations of two conventional FAZ metrics, two novel FAZ metrics, and EAA with DR severity and BCVA, as determined by Early Treatment Diabetic Retinopathy Study (ETDRS) charts, were assessed. Results: Sixty-six eyes from 66 diabetic patients and 19 control eyes from 19 healthy participants were included. The agreement between manual and automated FAZ delineation had a Jaccard index > 0.82, and the repeatability of automated FAZ detection was excellent in eyes at all levels of DR severity. FAZ metrics that incorporated both FAZ size and shape irregularity had the strongest correlation with clinical DR grade and BCVA. Of all the tested OCTA metrics, EAA had the greatest sensitivity in differentiating diabetic eyes without clinical evidence of retinopathy, mild to moderate nonproliferative DR (NPDR), and severe NPDR to proliferative DR from healthy controls. Conclusions: The GGVF snake algorithm tested in this study can accurately and reliably detect the FAZ, using OCTA data at all DR severity grades, and may be used to obtain clinically useful information from OCTA data regarding macular ischemia in patients with diabetes. While FAZ metrics can provide clinically useful information regarding macular ischemia, and possibly visual acuity potential, EAA measurements may be a better biomarker for DR.
KW - Diabetic retinopathy
KW - Microcirculation
KW - OCT angiography
KW - Optical coherence tomography
UR - http://www.scopus.com/inward/record.url?scp=85046336034&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046336034&partnerID=8YFLogxK
U2 - 10.1167/iovs.17-23498
DO - 10.1167/iovs.17-23498
M3 - Article
C2 - 29715365
AN - SCOPUS:85046336034
VL - 59
SP - 2212
EP - 2221
JO - Investigative Ophthalmology and Visual Science
JF - Investigative Ophthalmology and Visual Science
SN - 0146-0404
IS - 6
ER -